Karahan, T. O. Et Al. 2025. Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial. LIFE-BASEL , no.5 .

Karahan, T. O., Akyuz, E. Y., Karadag, D. Y., Yılmaz, Y., & Eren, F., (2025). Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial. LIFE-BASEL , no.5.

Karahan, Tugce Et Al. "Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial," LIFE-BASEL , no.5, 2025

Karahan, Tugce O. Et Al. "Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial." LIFE-BASEL , no.5, 2025

Karahan, T. O. Et Al. (2025) . "Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial." LIFE-BASEL , no.5.

@article{article, author={Tugce Ozlu Karahan Et Al. }, title={Effects of Intermittent Fasting on Liver Steatosis and Fibrosis, Serum FGF-21 and Autophagy Markers in Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial}, journal={LIFE-BASEL}, year=2025}